Synonyms- |
Introduction- |
Target |
Mechanism c-Met inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date14 Nov 2023 |
Target |
Mechanism c-Met inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date22 Jun 2021 |
Mechanism EGFR exon 20 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date22 Mar 2023 |
Sponsor / Collaborator |
Start Date03 Aug 2022 |
Sponsor / Collaborator |
Start Date31 May 2022 |
Sponsor / Collaborator- |